
About Aquagene
Aquagene was a Healthcare company based in Alachua (United States) founded in 1996. It produces high-quality recombinant proteins for research and industrial applications. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Recombinant Proteins and Production and Manufacturing. Its competitors include Encodia, Tierra Biosciences and Amide Technologies; 3 of its 3 listed competitors have raised funding.
Company details
Aquagene produces high-quality recombinant proteins for research and industrial applications, focusing on providing healthcare solutions, advancing biotech innovations, recombinant proteins, and production and manufacturing. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Alachua, United States
- SectorsHealthcare
- Website aquagene.com
- Latest Funding Round$400K (USD), Unspecified
Nov 2001
- Investors
Funding Insights of Aquagene
- Total Rounds 2
- Last Round Unspecified β $400,000
- First Round $580,000
(Jun 2000)
- Investors Count 1
All 2 funding rounds of Aquagene with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2001 | $400,000 | Unspecified | β | β | |
| Jun 2000 | $580,000 | Unspecified | β | β |
1 investors in total: 1 institutional.
Investors in Aquagene
Aquagene has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Advantage Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investment firm | advantagecap.com | New Orleans, United States |
Investor details for Aquagene
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aquagene
3 dated milestones of Aquagene across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Aquagene is founded.
- Funding First funding round of $580K.
- Funding Latest funding round, Unspecified, of $400K.
Competitors of Aquagene
Aquagene has 3 listed competitors in our database, 3 of them funded. They include Encodia, Tierra Biosciences and Amide Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| encodia.com | 2015 | San Diego, United States | $75M | 85 | Technology platforms for integrative proteomic analysis are developed. | |
| tierrabiosciences.com | 2015 | Berkeley, United States | $31.56M | 11 | AI-based tools for protein development and custom synthesis are offered. | |
| amidetech.com | 2017 | Cambridge, United States | $16.5M | 8 | Automated peptide synthesis platform is developed with precision reagents. |
Detailed competitors of Aquagene
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Aquagene (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aquagene
Aquagene was founded in 1996 and raised its 1st funding round 4 years after it was founded.
Aquagene is headquartered in Alachua, United States. It is registered at Alachua, Florida, United States.
Aquagene produces high-quality recombinant proteins for research and industrial applications, focusing on providing healthcare solutions, advancing biotech innovations, recombinant proteins, and production and manufacturing. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Aquagene's top competitors include Encodia, Tierra Biosciences and Amide Technologies.
Aquagene has 1 investor. Key investors include Advantage Capital.